All lobbying filings

CAMBIA HEALTH SOLUTIONS

Lobbying for CAMBIA HEALTH SOLUTIONS

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · District of Columbia · House · Senate · $620,000.00 expenses · posted Apr 21, 2025

Official filing document

Bills named in this filing 9

HR 257
SEC Act of 2025
S 46
Health Care Affordability Act of 2025
S 976
Insurance Fraud Accountability Act
S 891
Bipartisan Health Care Act
S 1096
Preserve Access to Affordable Generics and Biosimilars Act
S 1040
Drug Competition Enhancement Act
S 882
Patients Before Middlemen Act
S 205
Protecting Individuals with Down Syndrome Act
HR 1968
To provide for a limitation on availability of funds for Department of Health and Human Services, Centers for Disease C…

Lobbying activity 2

Health Issues

Affordable Care Act - extending enhanced APTCs (H.R. 257; S. 46) and fraudulent enrollments in qualified health plans (S. 976), Individual Coverage Health Reimbursement Arrangements, Behavioral Health, Employer-Provided Health Coverage, Surprise Billing, Cybersecurity, Health IT, Health Care Innovation, Transparency & PBMs (S. 891, Sec. 901, Sec. 902), Prescription Drugs (S. 1096, S.1040), Telehealth Extending Flexibilities (S. 891, Sec. 1001)

Medicare/Medicaid

Medicare Advantage (Star Ratings, Risk Adjustment, Health Equity Index, Supplemental Benefits), Medicare Prior Authorization and Electronic Prior Authorization, Provider Directories (S. 891, Sec. 223), Telehealth Extending Flexibilities (H.R. 1968, Sec. 2207), Transparency & PBMs (S. 882; S. 891, Sec. 227), Physician Fee Schedule (S. 891, S. 205), Site Neutrality & Provider Billing (S. 891, Sec. 228), Medicare Coverage & Obesity, FY25 Concurrent Budget Resolution (potential Medicare and Medicaid Policies)

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.